AHIA
VRTX icon

Andrew Hill Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Andrew Hill Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57M Buy
13,232
+1,277
+11% +$566K 4.88% 3
2026
Q1 		$5.34M Sell
11,955
-453
-4% -$211K 4.76% 2
2025
Q4 		$5.63M Buy
12,408
+8,699
+235% +$3.75M 4.28% 9
2025
Q3 		$1.45M Sell
3,709
-4,294
-54% -$1.79M 1.13% 26
2025
Q2 		$3.56M Buy
8,003
+1,430
+22% +$659K 2.87% 17
2025
Q1 		$3.19M Buy
6,573
+19
+0.3% +$8.85K 3.08% 14
2024
Q4 		$2.64M Sell
6,554
-2,335
-26% -$1.08M 1.96% 22
2024
Q3 		$4.13M Sell
8,889
-65
-0.7% -$31.2K 3.1% 14
2024
Q2 		$4.2M Buy
8,954
+32
+0.4% +$13.9K 3.48% 10
2024
Q1 		$3.73M Sell
8,922
-3,340
-27% -$1.41M 3.29% 8
2023
Q4 		$4.99M Buy
+12,262
New +$4.53M 5.2% 2
2022
Q3 		$4.38M Buy
+15,138
New +$4.36M 5.95% 4

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Andrew Hill Investment Advisors's VRTX Position: Q2 2026 in Review

Andrew Hill Investment Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q2 2026, buying an estimated $566K and bringing the position to 13,232 shares worth $6.57M. The position accounts for 4.88% of the portfolio, ranked #3.

Andrew Hill Investment Advisors first reported a position in VRTX in Q3 2022 and has held it in 12 quarters since. 595 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Andrew Hill Investment Advisors held 13,232 shares of Vertex Pharmaceuticals worth $6.57M as of Q2 2026.
  • Andrew Hill Investment Advisors bought 1,277 Vertex Pharmaceuticals shares in Q2 2026, an estimated $566K.
  • Vertex Pharmaceuticals made up 4.88% of Andrew Hill Investment Advisors's portfolio in Q2 2026, its #3 holding.
  • Andrew Hill Investment Advisors first reported a position in Vertex Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
  • 595 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Andrew Hill Investment Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.